Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
382 people get CDXS articles and Market Currents by email alert.
Get email alerts on CDXS »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Business Wire (May 14, 2013)
-
Business Wire (May 7, 2013)
-
Business Wire (Apr 29, 2013)
-
Business Wire (Apr 22, 2013)
-
Business Wire (Mar 12, 2013)
-
-
Business Wire (Feb 27, 2013)
-
Business Wire (Feb 19, 2013)
-
Business Wire (Feb 15, 2013)
-
Business Wire (Feb 14, 2013)
-
PR Newswire (Feb 13, 2013)
-
Codexis' CEO Discusses Q3 2012 Results - Earnings Call TranscriptWed, Nov 7, 2012
-
Business Wire (Nov 7, 2012)
-
Business Wire (Oct 24, 2012)
-
-
Business Wire (Sep 13, 2012)
-
Business Wire (Sep 12, 2012)
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
3 Healthcare Companies Poised For A Short-Term PopMatt Schilling • Fri, Apr 27, 2012 -
-
-
-
U.S. IPO Index Continues To Outperform In FebruaryRenaissance Capital IPO Research • Wed, Feb 15, 2012 -
-
-
-
-
-
-
-
12 Smart Money Biotech Picks Releasing Earnings Next WeekKapitall • Thu, Oct 27, 2011
-
-
12 Oversold Biotech Stocks Being Bought Up By Smart MoneyKapitall • Wed, Sep 14, 2011
-
-
Codexis' CEO Discusses Q3 2012 Results - Earnings Call TranscriptWed, Nov 7, 2012
-
Codexis' CEO Discusses Q2 2012 Results - Earnings Call TranscriptThu, Aug 9, 2012 • 1 Comment
-
Business Wire (May 14, 2013)
-
Business Wire (May 7, 2013)
-
Business Wire (Apr 29, 2013)
-
Business Wire (Apr 22, 2013)
-
Business Wire (Mar 12, 2013)
-
Business Wire (Feb 27, 2013)
-
Business Wire (Feb 19, 2013)
-
Business Wire (Feb 15, 2013)
-
Business Wire (Feb 14, 2013)
-
PR Newswire (Feb 13, 2013)
-
Business Wire (Nov 7, 2012)
-
Business Wire (Oct 24, 2012)
-
Business Wire (Sep 13, 2012)
-
Business Wire (Sep 12, 2012)
-
Business Wire (Sep 4, 2012)
-
Business Wire (Sep 4, 2012)
-
at Fox Business (Aug 21, 2012)
-
Business Wire (Aug 9, 2012)
-
Business Wire (Jul 26, 2012)
-
Business Wire (Jul 16, 2012)
CDXS vs. ETF Alternatives
Company Description
Currently, there's no company description for CDXS.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Tuesday, May 7, 4:38 PM Codexis (CDXS): Q1 EPS of -$0.25 beats by $0.08. Revenue of $11.5M. (PR) Comment! [Earnings, Breaking News]
- Tuesday, May 7, 12:10 AM Notable earnings after Tuesday’s close: ANDE, ARAY, AWK, AXLL, BIO, BIOL, BMC, BWC, CA, CDXS, CHRW, CODI, DGI, DGIT, DIS, DVA, EA, ENPH, EXEL, GA, GPOR, HTA, IAG, JAZZ, KGC, LYV, MAKO, MCEP, MCK, MDLZ, MITK, MRO, MYGN, NVTL, OAS, OCLR, OHI, ONXX, ORA, PRI, RBCN, SD, SGEN, SYMC, SYNC, TRIP, TWO, URS, VCLK, WBMD, WFM, WMB, WPZ, WTI, Z 1 Comment [Earnings]
- Monday, May 6, 5:35 PM Notable earnings after Tuesday’s close: ANDE, ARAY, AWK, AXLL, BIO, BIOL, BMC, BWC, CA, CDXS, CHRW, CODI, DGI, DGIT, DIS, DVA, EA, ENPH, EXEL, GTEK, GA, GPOR, IAG, JAZZ, KGC, LYV, MAKO, MCEP, MCK, MDLZ, MITK, MRO, MYGN, NVTL, OAS, OCLR, OHI, ONXX, ORA, PRI, RBCN, SD, SGEN, SYMC, SYNC, TRIP, TWO, URS, VCLK, WBMD, WFM, WMB, WPZ, WTI, Z 1 Comment [Earnings]
- Wednesday, February 27, 4:16 PM Codexis (CDXS): Q4 EPS of -$0.41 misses by $0.07. Revenue of $7.9M (-76% Y/Y). (PR) Comment! [Earnings, Breaking News]
- Wednesday, February 27, 12:10 AM Notable earnings after Wednesday’s close: AGO, AHT, ANW, ARI, CBI, CDXS, CECO, CLR, DAR, DPM, DVR, GRPN, HNSN, IOC, ITC, JCP, LTD, MBI, MMLP, MNST, MWE, MYL, PANL, PLL, RGR, UAN, WES, WLL Comment! [Earnings]
- Tuesday, February 26, 5:35 PM Notable earnings after Wednesday’s close: AGO, AHT, ANW, ARI, CBI, CDXS, CECO, CLR, DAR, DPM, DVR, GRPN, HNSN, IOC, ITC, JCP, LTD, MBI, MMLP, MNST, MWE, MYL, PANL, PLL, RGR, UAN, WES, WLL 1 Comment [Earnings]
-
Monday, January 7, 12:45 PM
Midday top 10 gainers: PPHM +67%. MDCI +28%. DLGC +24%. EPOC +22%. BIOL +21%. RFIL +21%. BITA +16%. PRGN +15%. CHRM +15%. CBMX +15%.
Midday top 10 Losers: HILL -20%. ESI -17%. STP -13%. SWSH -11%. PGRX -11%. PSEM -11%. IHT -11%. CDXS -10%. ACHN -10%. NED -9%. Comment! [On the Move] -
Friday, November 30, 2012, 5:46 PM
After-hours top gainers, as of 5:15 p.m.: NTLS +25.2%. GAI +10.2%. CBE +5.8%. GEO +5.4%. SYRG +2.8%.
After-hours top losers: SCMP -8.4%. CDXS -3.3%. JRCC -2.9%. BKW -2.8%. GFIG -2.7%. 1 Comment [On the Move] - Wednesday, November 7, 2012, 5:01 PM Codexis (CDXS): Q3 EPS of -$0.06 beats by $0.12. Revenue of $26.3M (-20.9% Y/Y) beats by $2M. (PR) Comment! [Earnings]
- Friday, August 10, 2012, 12:37 PM Codexis (CDXS -20%) shares are crushed after the biofuels maker says in its Q2 report that it won’t receive further funding from Royal Dutch Shell (RDS.A, RDS.B) for research into converting biomass to fuel. Shares are cut to Neutral from Outperform at Credit Suisse. 1 Comment [Energy, On the Move]
- Thursday, August 9, 2012, 5:12 PM Codexis (CDXS): Q2 EPS of -$0.15 may not be comparable to consensus of -$0.18. Revenue of $22.9M (-12.1% Y/Y) misses by $7M. Shares -12.9% AH (PR) Comment! [Earnings, Healthcare, On the Move]
- Monday, July 16, 2012, 4:23 PM Codexis (CDXS) +11.4% AH after signing an exclusive negotiation agreement with Royal Dutch Shell (RDS.A, RDS.B) which would grant to CDXS certain rights and licenses in the biofuels field to develop and sell cellulase enzymes to third parties on a worldwide basis except Brazil. Comment! [Energy, On the Move]
- Thursday, May 10, 2012, 5:43 PM Codexis (CDXS): Q1 comes in mixed, beating on revenue but missing on its EPS. Losses widened as the biotechnology company recorded higher sales and R&D expenses and flat revenue. For FY12, the company sees revenue in-line with or slightly exceeding the prior-year. Street estimates are for 3% growth. Shares -7.4% AH. Comment! [Healthcare, Earnings]
- Thursday, May 10, 2012, 4:42 PM Codexis (CDXS): Q1 EPS of -$0.21 misses by $0.06. Revenue of $31.1M (flat Y/Y) beats by $0.3M. Shares -4.7% AH. (PR) 1 Comment [Earnings, Healthcare, On the Move]
-
Wednesday, April 25, 2012, 9:06 AM
Premarket gainers: GEOI +21%. KND +17%. CDXS +9%. AAPL +9%. S +8%. TQNT +8%. JNY +6%. DAN +6%. RFMD +6%. GLW +5%. MOS +5%. ARMH +5%. MT +5%. BRCM +5%. NBR +4%. CLWR +4%. ALU +4%. FTNT +4%. STM +4%. POT +4%. HOG +4%. BBVA +4%. TS +3%. NOK +3%. STD +3%. TEF +3%. VMED +3%. IGT +3%.
Losers: ICON -14%. BIDU -6%. GSK -3%. Comment! [On the Move] - Wednesday, April 25, 2012, 8:48 AM Codexis (CDXS) +8.5% premarket after announcing the FDA approved a new process it co-developed for manufacturing sitagliptin, the active pharmaceutical ingredient in Merck's (MRK) Januvia diabetes drug. Comment! [Healthcare, On the Move]